Skip to main content

Table 2 General data for the evaluated patients

From: High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection

 

ANA-positive

ANA-negative

p-value

Age

55.55 ± 8.3

53.71 ± 10.77

0.9526T

Female sex

9 (50%)

32 (45.08%)

0.9124Q

Alcohol consumption

8 (44.44%)

33 (50%)

0.6766Q

Smoking

6 (33.33%)

21 (31.34%)

0.8721Q

Injectable drugs

2 (12.5%)

4 (6.06%)

0.5908E

Inhalant drugs

2 (12.5%)

5 (7.58%)

0.8963Q

Previous hepatitis

2 (11.76%)

10 (14.71%)

0.7308E

  1. EFisher's exact test; QChi-square test; TT test